(Q44345409)

2 December 2017

title

Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors (English)

1 reference

2 December 2017

Philip E J Sanderson

1

1 reference

2 December 2017

Matthew G Stanton

2

1 reference

2 December 2017

Bruce D Dorsey

3

1 reference

2 December 2017

Terry A Lyle

4

1 reference

2 December 2017

Colleen McDonough

5

1 reference

2 December 2017

William M Sanders

6

1 reference

2 December 2017

Kelly L Savage

7

1 reference

2 December 2017

Adel M Naylor-Olsen

8

1 reference

2 December 2017

Julie A Krueger

9

1 reference

2 December 2017

S Dale Lewis

10

1 reference

2 December 2017

Bobby J Lucas

11

1 reference

2 December 2017

Joseph J Lynch

12

1 reference

2 December 2017

Youwei Yan

13

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

2 December 2017

volume

13

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

795-798

1 reference

Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

Thrombin inhibitors. 3. Carboxyl-containing amide derivatives of N alpha-substituted L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900017-9

7 January 2021

10.1016/S0960-894X(03)00017-9

Identifiers

DOI

1 reference

2 December 2017

1 reference